Business
Why the Mesoblast (ASX:MSB) share price is sinking 11% lower – The Motley Fool Australia
The Mesoblast limited (ASX:MSB) share price is sinking lower on Tuesday. Here’s what you need to know…
The Mesoblast limited(ASX: MSB) share price has come under pressure on Tuesday after the release of an announcement.
At the time of writing the allogeneic cellular medicines developer’s shares are down 11% to $4.03.
What did Mesoblast announce?
This morning Mesoblast announced the top-line results from the landmark DREAM-HF Phase 3 randomised controlled trial of its allogeneic cell therapy rexlemestrocel-L (REVASCOR) in 537 patients with advanced chronic heart failure.
According to the release,…
-
Noosa News20 hours agoAre speeding fines suitability issues? – Proctor
-
Noosa News23 hours agoElderly man, 88, charged with attempted murder of woman west of Brisbane
-
Noosa News22 hours agoFrom Cosy Hotel Stays To New Exhibitions: How To Master a Sydney Winter Escape
-
Noosa News18 hours agoTen people narrowly escape devastating Inala fire in share house without smoke alarms